Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use

Drugs
Sabrina BagaglioGiulia Morsica

Abstract

Multiple direct-acting antiviral (DAA)-based regimens are currently approved that provide one or more interferon-free treatment options for hepatitis C virus (HCV) genotypes (G) 1-6. The choice of a DAA regimen, duration of therapy, and use of ribavirin depends on multiple viral and host factors, including HCV genotype, the detection of resistance-associated amino acid (aa) substitutions (RASs), prior treatment experience, and presence of cirrhosis. In regard to viral factors that may guide the treatment choice, the most important is the infecting genotype because a number of DAAs are genotype-designed. The potency and the genetic barrier may also impact the choice of treatment. One important and debated possible virologic factor that may negatively influence the response to DAAs is the presence of baseline RASs. Baseline resistance testing is currently not routinely considered or recommended for initiating HCV treatment, due to the overall high response rates (sustained virological response >90%) obtained. Exceptions are patients infected by HCV G1a when initiating treatment with simeprevir and elbasvir/grazoprevir or in those with cirrhosis prior to daclatasvir/sofosbuvir treatment because of natural polymorphisms demonstrate...Continue Reading

References

Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A M Di Bisceglie
Oct 16, 2004·The Journal of General Virology·Peter Simmonds
Sep 9, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Peter SimmondsAnders Widell
Oct 17, 2007·Antimicrobial Agents and Chemotherapy·Yi ZhouChao Lin
Sep 30, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Simone SusserChristoph Sarrazin
Jun 30, 2010·Antimicrobial Agents and Chemotherapy·Robert A FridellMin Gao
Dec 3, 2011·Proceedings of the National Academy of Sciences of the United States of America·Megan H PowdrillMatthias Götte
Mar 21, 2012·Antimicrobial Agents and Chemotherapy·Angela M LamPhillip A Furman
Apr 18, 2012·Antimicrobial Agents and Chemotherapy·Fiona McPheeClaudio Pasquinelli
Feb 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jeremie GuedjAlan S Perelson
Mar 19, 2014·Gastroenterology·Jean-Michel Pawlotsky
Apr 12, 2014·The New England Journal of Medicine·Kris V KowdleyUNKNOWN ION-3 Investigators
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-2 Investigators
Aug 16, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric F DonaldsonLisa K Naeger
Oct 1, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anita Y M HoweNiloufar Mobashery
Dec 24, 2014·Antimicrobial Agents and Chemotherapy·Warren KatiChristine Collins
Feb 26, 2015·Antimicrobial Agents and Chemotherapy·Simone SusserChristoph Sarrazin
Jun 23, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Erik LontokVeronica Miller
Nov 1, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Donald M JensenUNKNOWN ANNAPURNA study investigators
Dec 26, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric LawitzJames Witek
Jan 23, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul KwoJames Witek
Jan 24, 2016·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Ilaria VicentiMaurizio Zazzi

❮ Previous
Next ❯

Citations

Jan 14, 2018·Digestive Diseases and Sciences·Enass A Abdel-HameedKenneth E Sherman
Jan 24, 2019·Clinical and Molecular Hepatology·Nadia MarascioCarlo Torti
Jul 19, 2019·Critical Reviews in Clinical Laboratory Sciences·Lize CuypersMahmoud Reza Pourkarim
Jun 21, 2019·Molecular Genetics & Genomic Medicine·Yuzhu SongA-Mei Zhang
Feb 1, 2020·Expert Opinion on Drug Metabolism & Toxicology·Valentina ZuccaroRaffaele Bruno
Aug 29, 2018·Antimicrobial Agents and Chemotherapy·Ernest Asante-AppiahJoseph Kozlowski
Feb 23, 2020·Vaccines·Joshua D DuncanJonathan K Ball
Aug 28, 2020·Microbial Cell Factories·Prem ChandraPankaj Kumar Arora
Mar 25, 2019·Oxidative Medicine and Cellular Longevity·Simona AnticoliAnna Ruggieri
Feb 11, 2021·Journal of Clinical Medicine·Isidoro MartínezSalvador Resino
Sep 15, 2020·European Journal of Medicinal Chemistry·Deepthi RameshTharanikkarasu Kannan
Aug 29, 2021·Pharmaceuticals·Nour Mammari On Behalf Of The Oemonom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.